Tagip 50mg treats type 2 diabetes by lowering blood sugar through DPP-4 enzyme inhibition. It is taken once daily, with or without food, alongside diet and exercise. Buy Tagip 50mg online at PakMeds and save on genuine, prescription verified medicine delivered to your door.

Tagip 50mg Ingredients and Usage

Tagip 50mg contains sitagliptin — an oral hypoglycemic agent belonging to the DPP-4 inhibitor (dipeptidyl peptidase 4 inhibitor) drug class. It controls blood glucose levels in adults with type 2 diabetes mellitus. It is used alongside diet and exercise, either alone or in combination with other antidiabetic medicines.

Tagip 50mg works well in combination with metformin, sulfonylureas, or insulin when single agent therapy is insufficient. Unlike some diabetes medicines, sitagliptin is weight neutral and does not typically cause weight gain. Tagip is not indicated for type 1 diabetes or diabetic ketoacidosis.

How Does Tagip 50mg Work?

Tagip 50mg selectively inhibits the enzyme dipeptidyl peptidase 4 (DPP-4). DPP-4 normally breaks down incretin hormones — specifically GLP-1 (glucagon-like peptide 1) and GIP (glucose dependent insulinotropic polypeptide). By blocking DPP-4, Tagip prolongs the action of these hormones in the body.

Elevated incretin levels stimulate the pancreas to release more insulin when blood glucose is high. They also signal the liver to reduce glucose production and suppress glucagon secretion. This dual action lowers blood sugar effectively without causing hypoglycemia when sitagliptin is used alone.

Tagip 50mg Side Effects

Tagip 50mg is generally well tolerated in most patients with type 2 diabetes. The most commonly reported adverse effects, as documented by the NHS and FDA, include:

• Headache — the most common side effect, occurring in more than 1 in 100 patients
• Nasopharyngitis — upper respiratory tract symptoms including runny nose and sore throat
• Nausea — mild gastrointestinal discomfort, particularly in early treatment
• Hypoglycemia — low blood sugar, mainly when combined with insulin or sulfonylureas
• Severe arthralgia — disabling joint pain; discontinue and inform your doctor if this occurs
• Dizziness or blurred vision — avoid driving until you know how the medicine affects you
• Bullous pemphigoid — rare skin blistering condition reported with DPP-4 inhibitor use

Warnings

• Pancreatitis risk: Stop Tagip immediately if you experience severe upper abdominal pain radiating to the back. The FDA has issued an alert linking sitagliptin to acute pancreatitis, including fatal cases.
• Renal impairment: Sitagliptin is eliminated primarily through the kidneys. Dose adjustment is required for patients with moderate to severe renal impairment. Monitor kidney function regularly during treatment.
• Hypersensitivity reactions: Serious allergic reactions including anaphylaxis, angioedema, and Stevens-Johnson syndrome have been reported. Discontinue immediately if signs of a severe reaction appear.
• Heart failure: Use with caution in patients with a history of heart failure. DPP-4 inhibitors carry an elevated risk of acute heart failure hospitalisation in at-risk patients.
• Insulin and sulfonylurea interaction: Combining Tagip with insulin or sulfonylureas (e.g. gliclazide, glimepiride) raises the risk of hypoglycemia. Your doctor may reduce the dose of the other medicine.
• Pregnancy and breastfeeding: Safety in pregnancy has not been fully established. Use only if the benefit outweighs the risk, under direct medical supervision. Breastfeeding while taking Tagip is not recommended without physician guidance.
• Type 1 diabetes: Tagip 50mg is contraindicated in patients with type 1 diabetes or diabetic ketoacidosis — it will not work and may cause harm.

Tagip 50mg Storage Conditions

• Store at room temperature between 20°C and 25°C (68°F to 77°F)
• Brief exposure up to 30°C is acceptable — for example during transport
• Keep in the original packaging in a cool, dry place away from heat and moisture
• Do not store in the bathroom — humidity degrades the tablets
• Keep out of reach of children at all times
• Dispose of expired or unused tablets via a pharmacist take-back program — do not flush or discard in household waste

Tagip 50mg Price in Pakistan

Tagip 50mg is available in Pakistan at approximately Rs. 238 to Rs. 378 per pack of 14 tablets. Prices vary across online pharmacies — Healthwire lists it at around Rs. 238, while other platforms price it up to Rs. 378 per pack.

Generic sitagliptin alternatives are available in Pakistan at varying price points, which may offer a more affordable option. PakMeds offers competitive pricing on genuine Highnoon stock with fast, verified delivery — order Tagip 50mg at PakMeds today and save on your diabetes treatment.

Tagip 50mg — Frequently Asked Questions

Does Tagip 50mg cause low blood sugar (hypoglycemia)?

Tagip 50mg does not typically cause hypoglycemia when taken alone. Sitagliptin only stimulates insulin release when blood glucose is already elevated — this is called a glucose dependent mechanism. This makes it safer than older diabetes medicines like sulfonylureas, which can cause blood sugar to drop at any time.

Hypoglycemia can occur when Tagip is combined with insulin, gliclazide, or other sulfonylureas. Your doctor may lower the dose of the other medicine to reduce this risk. Always carry a quick source of sugar such as glucose tablets when starting combination therapy.

How and when should I take Tagip 50mg?

Take one Tagip 50mg tablet once daily, with or without food, at the same time each day. Swallow the tablet whole with a glass of water — do not crush or chew it. Taking it with food can reduce mild nausea in some patients during the first few weeks.

If you miss a dose, take it as soon as you remember on the same day. Do not double up doses the following day. Continue your regular schedule and inform your doctor if you miss multiple doses, as this can affect your blood sugar control.

Can Tagip 50mg be used with Metformin?

Yes — sitagliptin and metformin are commonly prescribed together for type 2 diabetes management. The two medicines work through different mechanisms, making the combination more effective than either drug alone. Highnoon also manufactures Tagipmet, a fixed dose combination tablet containing both sitagliptin and metformin.

Your doctor will assess your HbA1c levels and kidney function before adding sitagliptin to metformin. Both medicines are generally well tolerated together, with no significant pharmacokinetic interaction between them. Regular HbA1c monitoring every 3 to 6 months is recommended to track blood sugar control.